CZA | MDY | CZA / MDY | |
Gain YTD | 5.399 | 6.450 | 84% |
Net Assets | 183M | 24.1B | 1% |
Total Expense Ratio | 0.69 | 0.24 | 288% |
Turnover | 112.00 | 20.43 | 548% |
Yield | 1.21 | 1.15 | 105% |
Fund Existence | 18 years | 30 years | - |
CZA | MDY | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago82% | 4 days ago86% |
Momentum ODDS (%) | 4 days ago80% | 4 days ago86% |
MACD ODDS (%) | 4 days ago87% | 4 days ago85% |
TrendWeek ODDS (%) | 4 days ago75% | 4 days ago84% |
TrendMonth ODDS (%) | 4 days ago81% | 4 days ago82% |
Advances ODDS (%) | 4 days ago81% | 4 days ago83% |
Declines ODDS (%) | 6 days ago74% | 6 days ago83% |
BollingerBands ODDS (%) | 4 days ago66% | 4 days ago84% |
Aroon ODDS (%) | 4 days ago79% | 4 days ago82% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WGUSX | 15.25 | 0.21 | +1.40% |
Wasatch US Select Inst | |||
MAPPX | 27.49 | 0.26 | +0.95% |
Morgan Stanley Inst Advantage A | |||
LGOTX | 36.62 | 0.10 | +0.27% |
Lord Abbett Growth Opportunities R5 | |||
BMRRX | 34.71 | 0.09 | +0.26% |
BlackRock Mid-Cap Growth Equity R | |||
NRARX | 52.59 | -0.34 | -0.64% |
Neuberger Berman Quality Equity R3 |
A.I.dvisor tells us that CZA and IVZ have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CZA and IVZ's prices will move in lockstep.
A.I.dvisor indicates that over the last year, MDY has been closely correlated with AVNT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if MDY jumps, then AVNT could also see price increases.
Ticker / NAME | Correlation To MDY | 1D Price Change % | ||
---|---|---|---|---|
MDY | 100% | +0.47% | ||
AVNT - MDY | 79% Closely correlated | +1.13% | ||
FHN - MDY | 76% Closely correlated | -2.41% | ||
CG - MDY | 73% Closely correlated | -1.82% | ||
GGG - MDY | 73% Closely correlated | -0.38% | ||
IBOC - MDY | 72% Closely correlated | -1.15% | ||
More |